ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

86 filings reported holding SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 50.2M shares of 98.6M outstanding shares and own 50.89% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (11.1M shares), ORBIMED ADVISORS LLC (8.74M shares), FMR LLC (5.37M shares), RA CAPITAL MANAGEMENT, L.P. (3.01M shares), SR ONE CAPITAL MANAGEMENT, LP (3.01M shares), Rubric Capital Management LP (2.99M shares), K2 PRINCIPAL FUND, L.P. (2.87M shares), BAKER BROS. ADVISORS LP (2.01M shares), Nextech Invest Ltd. (1.91M shares), and VANGUARD GROUP INC (1.69M shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.